Showing results (681-690 of 735) with videos related to

Sort By:
Pageof 74
Eclinicalmedicine|December 30, 2022
A novel combination of niraparib and anlotinib in platinum-resistant ovarian cancer: Efficacy and safety results from the phase II, multi-center ANNIE studyGuochen Liu, Yanling Feng, Jing Li, et al.
Gynecologic Oncology|November 30, 2020
Olaparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer and a BRCA1 and/or BRCA2 mutation: SOLO1 China cohortLingying Wu, Jianqing Zhu, Rutie Yin, et al.
Asia-Pacific Journal of Clinical Oncology|March 31, 2022
Olaparib maintenance monotherapy in Chinese patients with platinum-sensitive relapsed ovarian cancer: China cohort from the phase III SOLO2 trialJihong Liu, Rutie Yin, Lingying Wu, et al.
Open Heart|September 24, 2025
Triglyceride-Glucose Index: a novel prognostic predictor for postoperative cerebral infarction in off-pump coronary artery bypass grafting - insights from a nationwide multicentre studyShipan Wang, Yilin Li, Hao Han, et al.
Plos One|August 11, 2012
LncRNAs expression signatures of renal clear cell carcinoma revealed by microarrayGan Yu, Weimin Yao, Ji Wang, et al.
Journal of Integrative Plant Biology|June 29, 2022
The divergence of brassinosteroid sensitivity between rice subspecies involves natural variation conferring altered internal auto-binding of OsBSK2Wenchao Yin, Lulu Li, Zhikun Yu, et al.
Journal of Gynecologic Oncology|June 14, 2024
First-line bevacizumab plus chemotherapy in Chinese patients with stage III/IV epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer: a phase III randomized controlled trialXiaohua Wu, Jihong Liu, Ruifang An, et al.
Neurourology and Urodynamics|September 5, 2019
The effects of microenergy acoustic pulses on an animal model of obesity-associated stress urinary incontinence. Part 1: Functional and histologic studiesBohan Wang, Yajun Ruan, Tie Zhou, et al.
Plant Biotechnology Journal|May 18, 2021
Hepatitis C virus E2 envelope glycoprotein produced in Nicotiana benthamiana triggers humoral response with virus-neutralizing activity in vaccinated miceMihaela-Olivia Dobrica, André van Eerde, Catalin Tucureanu, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|July 23, 2020
Phase I dose-escalation and expansion study of PARP inhibitor, fluzoparib (SHR3162), in patients with advanced solid tumorsHuiping Li, Rongrui Liu, Bin Shao, et al.
Pageof 74